Literature DB >> 14580328

Adding facets to TNF signaling. The JNK angle.

Zheng-gang Liu1.   

Abstract

In the October 3 issue of Cell, Deng et al. (2003) report that a JNK-dependent mitochondrial signal, the release of Smac/DIABLO, is required for TNF-induced caspase 8 activation and apoptosis. This process is interceded by a novel processed form of the BH3 only protein Bid.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14580328     DOI： 10.1016/s1097-2765(03)00399-x

Source DB:  PubMed          Journal:  Mol Cell        ISSN： 1097-2765            Impact factor:   17.970


  6 in total

1.  Inflammatory markers in skeletal muscle of older adults.

Authors:  Marissa K Caldow; David Cameron-Smith; Pazit Levinger; Michael J McKenna; Itamar Levinger
Journal:  Eur J Appl Physiol       Date:  2012-07-18       Impact factor: 3.078

2.  Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.

Authors:  Daniel P Sejas; Reena Rani; Yuhui Qiu; Xiaoling Zhang; Sara R Fagerlie; Hiroyasu Nakano; David A Williams; Qishen Pang
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

Review 3.  TNF-α signaling in Fanconi anemia.

Authors:  Wei Du; Ozlem Erden; Qishen Pang
Journal:  Blood Cells Mol Dis       Date:  2013-07-24       Impact factor: 3.039

4.  Targeting of TAK1 by the NF-kappa B protein Relish regulates the JNK-mediated immune response in Drosophila.

Authors:  Jin Mo Park; Helen Brady; Maria Grazia Ruocco; Huaiyu Sun; DeeAnn Williams; Susan J Lee; Tomohisa Kato; Normand Richards; Kyle Chan; Frank Mercurio; Michael Karin; Steven A Wasserman
Journal:  Genes Dev       Date:  2004-03-01       Impact factor: 11.361

5.  Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.

Authors:  Wanling Sun; Zhijie Wu; Zenghua Lin; Maile Hollinger; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Blood       Date:  2018-10-25       Impact factor: 22.113

6.  The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies.

Authors:  Luigi Di Luigi; Mariangela Sottili; Cristina Antinozzi; Gabriella Barbara Vannelli; Francesco Romanelli; Valeria Riccieri; Guido Valesini; Andrea Lenzi; Clara Crescioli
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.